18F-JK-PSMA-7

N/A

Report date: 2022/11/21 17:59:22

Base Information

Drug Name18F-JK-PSMA-7
Drug Alias Name18-F-JK-PSMA-7
ClassificationRadiation-emitting products > Radioactive diagnostic agent
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesItel Telecomunicazioni SRL
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A